In 2017, 1,127 cases of tuberculosis (TB) were reported in Texas, a rate of 4.0 per 100,000 population. TB can affect anyone but is more likely to be diagnosed in persons born in a foreign country where TB is prevalent, persons living with diabetes or HIV/AIDS, persons who abuse alcohol and other drugs, persons who live in congregate settings (including prisons and other detention centers), people who experience homelessness, and health care workers.
Risk Factors Associated with TB Cases Reported in Texas in 2017
TB is curable with proper treatment. However, some strains of TB are resistant to the drugs used for treatment. In 2017, eight people in Texas were diagnosed with multidrug resistant TB. There were no cases of extensively drug-resistant TB (XDR-TB) reported in Texas in 2017. XDR-TB is the most difficult form of TB to treat.
In Texas, 53 percent of reported TB cases in 2017 were among Hispanics, 19 percent were among African Americans, 9 percent were among Whites, and 20 percent were among Asians. TB rates are higher along the Texas-Mexico border. Co-infection with TB and diabetes is also more common along the border than in the rest of the state. Homelessness, TB/HIV co-infection is more commonly found in larger urban areas of Texas. 
Tuberculosis Treatment
Not everyone infected with the bacteria that cause tuberculosis becomes sick. Those who do have symptoms -such as a cough, fever, night sweats, weight loss, chest pain, or fatigue -are most likely suffering from TB disease. Those with TB disease may be infectious. Prompt treatment is essential to end symptoms and prevent disability or death. Those who are infected with TB bacteria but do not have any symptoms and have a normal chest x-ray have latent TB infection (LTBI). Those with LTBI still require treatment to decrease the risk of future TB disease.
DSHS provides TB treatment medications to public health clinics across Texas. These clinics treat patients with TB disease and LTBI. Also, people who are presumed to have TB (TB suspects) may be given treatment while their clinicians perform further testing to confirm or rule out TB disease.
Treating TB disease generally requires up to four medications given for six months. Treating individuals with drug-resistant TB requires costly medications that may be used for an extended period of time. LTBI is generally treated with one medication for 9-12 months. Treatment of suspects varies according to the outcome of their diagnostic tests.
